RecruitingNCT01893710
International (Pediatric) Peritoneal Biobank
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Heidelberg University
- Principal Investigator
- Claus P Schmitt, MDUniversity of Heidelberg, Center for Pediatric and Adolescent Medicine
- Intervention
- biopsy sampling(procedure)
- Enrollment
- 500 enrolled
- Eligibility
- 90 years · All sexes
- Timeline
- 2011 – 2028
Study locations (26)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Children's Mercy Hospital, Kansas City, Missouri, United States
- The Children´s Hospital of Philadelphia, Narberth, Pennsylvania, United States
- Department of Pediatrics, Medical University Vienna, Vienna, Austria
- UZ Ghent, Ghent, Belgium
- University Children's Hospital, Prague, Czechia
- Service de Néphrologie Pédiatrique, Hôpital Femme Mere Enfant, Lyon, France
- University Children's Hospital, Strasbourg, France
- Department of Medicine I (Nephrology), University of Heidelberg, Heidelberg, Baden-Wurttemberg, Germany
- University Children's Hospital, Berlin, Germany
- University Children's Hospital, Cologne, Germany
- University Children's Hospital, Essen, Germany
- UKE, University Children´s Hospital, Hamburg, Germany
- KfH Pediatric Kidney Center, Department of Pediatric Nephrology, University of Marburg, Marburg, Germany
- University Children's Hospital, Budapest, Hungary
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01893710 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT07328503CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University